STOCK TITAN

Veralto Corporation Form 4 Filings

VLTO NYSE

Every Form 4 that Veralto Corporation (VLTO) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow VLTO and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full VLTO filings page.

Rhea-AI Summary

Veralto Corp (VLTO) reported that officer Surekha Trivedi, SVP, Strategy & Sustainability, sold 986 shares of common stock on August 17, 2026 at $97.05 per share in an open‑market or private transaction. Following the sale, Trivedi directly holds 8,565 shares. The transaction was effected under a previously disclosed Rule 10b5‑1 trading plan adopted on May 18, 2026.

Rhea-AI Summary

Veralto Corp President and CEO Jennifer Honeycutt exercised employee stock options covering 7,097 shares of common stock at $28.767,097$101.52Rule 10b5-1 trading plan adopted on February 25, 2026. After the exercise, 7,098

Rhea-AI Summary

Veralto Corp director Thomas Williams reported a quarterly company contribution under the Non-Employee Directors' Deferred Compensation Plan, credited as 183 unfunded, notional shares of common stock on July 24, 2026 at $92.02 per notional share, increasing his deferred account balance to 183 equivalent shares.

Each notional share converts on a one-for-one basis into common stock, with vesting and distribution governed by the plan’s terms and his elections.

Rhea-AI Summary

Veralto Corp reported that director Cindy L. Wallis-Lage received a quarterly Company contribution under the Veralto Corporation Non-Employee Directors' Deferred Compensation Plan, credited as 38 notional shares of common stock at $92.02 per share on July 24, 2026. These unfunded, notional shares convert one-for-one into common stock, with vesting and distribution governed by the plan and her prior elections.

Rhea-AI Summary

Veralto Corp reported that director Heath A. Mitts received a quarterly company contribution under the Veralto Corporation Non-Employee Directors' Deferred Compensation Plan, deemed invested in 154.0000 unfunded, notional shares of Veralto common stock as of July 24, 2026 at a reference price of 92.0200 per notional share. Each notional share converts on a one-for-one basis into common stock, with vesting and distribution governed by the plan terms and the director’s elections as described in Veralto’s annual meeting proxy statement.

Rhea-AI Summary

Veralto President and CEO Jennifer Honeycutt exercised 7,097 employee stock options at $28.76 per share on July 17, 2026, receiving 7,097 common shares and selling 7,097 shares at $95.00 per share under a Rule 10b5-1 trading plan, leaving 14,195 options outstanding.

Rhea-AI Summary

Veralto Corp reported equity awards to director John T. Schwieters on 2026-07-15. He received 1,009 shares of Common Stock, described in a footnote as restricted stock units that vest on the earlier of the first anniversary of the grant date or the next annual shareholder meeting, with underlying shares issued only after specific retirement or death-related timing conditions.

On the same date he was also granted 3,553 Director Stock Options to buy Common Stock at an exercise price of $91.00 per share, which the company states are fully vested as of the grant date and expire on 2036-07-15. After these awards, direct holdings reported are 6,498 shares of Common Stock and 9,413 stock options.

Rhea-AI Summary

Veralto Corp director Thomas Williams received equity compensation on 2026-07-15. He was granted 1009.0000 restricted stock units tied to common stock, which vest by the next annual shareholder meeting and are issued only after his board service ends. He also received 3553.0000 fully vested director stock options with an exercise price of 91.0000 per share expiring on 2036-07-15, bringing his holdings to 3380.0000 common shares and 9413.0000 options.

Rhea-AI Summary

Wallis-Lage Cindy L. reported acquisition or exercise transactions in this Form 4 filing.

Veralto Corp director Cindy L. Wallis-Lage received equity awards. She was granted 1,009 restricted stock units that vest on the earlier of the first anniversary of the grant or the next annual shareholders meeting, with shares issued only after board retirement or death. She also received 3,553 fully vested director stock options to buy common shares at $91.00 per share, expiring in 2036, bringing her holdings to 3,380 common shares and 9,413 options held directly.

Rhea-AI Summary

Veralto Corp director Vijay P. Sankaran reported equity awards. On 2026-07-15 he received 1009.0000 restricted stock units that vest on the earlier of one year or the next annual shareholder meeting, with share delivery deferred until death or several months after board retirement. He was also granted 3553.0000 director stock options for common stock at an exercise price of $91.0000 per share, expiring on 2036-07-15, bringing his direct holdings to 2669.0000 common shares and 7823.0000 options.

Rhea-AI Summary

Veralto director Heath A. Mitts received equity awards on 2026-07-15, including 1,009 restricted stock units that vest by the earlier of the first anniversary or the next shareholder meeting, with shares issued upon the earlier of his death or the first date of the seventh month after board retirement. He also received 3,553 fully vested director stock options with a $91.00 exercise price expiring on 2036-07-15, bringing his direct holdings to 3,500 common shares and 9,413 options.

Rhea-AI Summary

Veralto director Walter G. Lohr received equity compensation on July 15, 2026, including 1,009 restricted stock units and 3,553 director stock options. The RSUs vest on the earlier of one year or the next shareholder meeting, with shares delivered after board service ends, while the options are fully vested, carry a $91 exercise price, and expire in 2036. Following these awards he holds 3,380 common shares and 9,413 options directly.

Rhea-AI Summary

Veralto Corp director William King received equity awards on 2026-07-15. He acquired 1,009 shares of common stock through a grant of restricted stock units that vest on the earlier of the first anniversary of the grant or the next annual shareholder meeting, with shares issued after he leaves the board.

He also received 3,553 director stock options for common stock at an exercise price of $91.00 per share, fully vested at grant and expiring on 2036-07-15. Following these awards he directly holds 9,557 common shares and 9,413 director stock options.

Rhea-AI Summary

Veralto Corp director Shyam Kambeyanda received equity compensation consisting of 1,099 restricted stock units tied to common stock and 3,553 director stock options with a $91.00 exercise price.

The RSUs vest on the earlier of the first anniversary of the grant date or immediately before the next annual shareholders’ meeting, while the underlying shares are issued only upon the earlier of the director’s death or seven months after retirement from the Board. The options are fully vested as of the grant date and expire on July 15, 2036. Following these grants, Kambeyanda holds 3,470 common shares and 9,413 stock options.

Rhea-AI Summary

Veralto director Daniel L. Comas received equity compensation on July 15, 2026, comprising 1,099 restricted stock units and 3,553 director stock options with a $91.00 exercise price. The RSUs vest by the first anniversary or next shareholder meeting with deferred share delivery; the options are fully vested at grant. After these awards he holds 18,509 common shares and 9,413 options, all reported as directly owned.

Rhea-AI Summary

Veralto Corp director Francoise Colpron reported equity awards dated 2026-07-15. She received 1,099 restricted stock units, which vest at the earlier of one year or the next shareholder meeting, and 3,553 director stock options at a $91.00 exercise price, fully vested at grant. She now holds 3,470 common shares and 9,413 options directly.

Rhea-AI Summary

Linda Filler, a director of Veralto Corp, received equity compensation on July 15, 2026. She was granted restricted stock units covering 825 and 1,009 shares of common stock, vesting on the earlier of one year from grant or the next annual shareholders meeting, with shares issued only at the earlier of her death or the first date of the seventh month after her retirement from the board. She was also granted director stock options for 2,665 and 3,553 shares at an exercise price of $91 per share, fully vested at grant and expiring on July 15, 2036.

Rhea-AI Summary

Veralto Corp SVP and Chief Financial Officer Sameer Ralhan had 3,305 shares of Common Stock withheld on 2026-07-15 to satisfy tax obligations, at a value of $91.00 per share. After this tax-withholding disposition, he directly owns 53,694 shares. This transaction is characterized under code F as payment of tax liability by delivering securities.

Rhea-AI Summary

Veralto Corp senior vice president and CHRO Lesley Beneteau reported a small, compensation-related share disposition. On a Form 4, Beneteau had 423 shares of Common Stock withheld at $84.83 per share to satisfy tax obligations. After this tax-withholding disposition, Beneteau directly holds 19,846 Common Stock shares.

Rhea-AI Summary

Veralto Corp’s Chief Accounting Officer Bernard M. Skeete sold 300 shares of Common Stock in an open-market transaction. The sale took place on May 1, 2026 at an average price of $88.21 per share. Following this sale, he directly holds 4,760 Veralto shares.

Rhea-AI Summary

Trivedi Surekha reported acquisition or exercise transactions in this Form 4 filing.

Veralto Corp reported that SVP of Strategy & Sustainability Surekha Trivedi received new equity awards on March 1, 2026. She was granted 7,824 employee stock options and 2,310 shares of common stock through restricted stock units. The RSUs and options vest in two equal parts on the third and fourth anniversaries of the grant date, tying her compensation to Veralto’s long-term performance.

Rhea-AI Summary

Veralto Corp Chief Accounting Officer Bernard M. Skeete reported equity awards and a small tax-related share disposition. On March 1, 2026, he received an employee stock option grant for 4,637 options at a price of $0.00 and a grant of 1,369 shares of common stock payable under restricted stock units.

According to the footnotes, one quarter of both the options and RSUs vest on each of the first, second, third, and fourth anniversaries of the March 1, 2026 grant date. On February 27, 2026, 103 shares of common stock were disposed of at $97.43 per share to satisfy tax obligations through a tax-withholding transaction, leaving 3,691 shares of common stock directly owned after that disposition and 5,060 shares following the later RSU grant.

Rhea-AI Summary

Veralto Corp reported that SVP and Chief Financial Officer Sameer Ralhan acquired new equity awards. He received 24,774 employee stock options and a grant of 7,313 shares of common stock at a price of $0.00 per share as compensation awards.

According to the footnotes, the common stock grant represents restricted stock units payable solely in common stock. One half of the RSUs vest on each of the third and fourth anniversaries of the grant date, which is March 1, 2026. One half of the options become exercisable on each of the third and fourth anniversaries of the same grant date.

Rhea-AI Summary

Veralto Corp senior vice president Melissa Kapity reported a mix of stock grants, option exercises, and share sales. On March 1, 2026, she received 15,213 employee stock options at an exercise price of $0 and 4,491 common shares as restricted stock units payable solely in stock. One half of these RSUs and one half of the options vest or become exercisable on each of the third and fourth anniversaries of the grant date.

On February 27, 2026, she exercised options covering 2,639 and 7,105 shares of common stock at an exercise price of $83.23 per share and then sold 14,840 shares of common stock in open-market transactions at $96.60 per share. After these transactions, she continued to hold common stock directly.

Rhea-AI Summary

Veralto Corp President and CEO Jennifer Honeycutt reported equity awards that increase her direct stake in the company. She received an option grant for 91,273 shares of common stock at a price of $0.00 per share, described as an employee stock option right to buy.

She also acquired 26,943 shares of common stock as a stock award at $0.00 per share, bringing her direct common stock holdings to 124,085 shares after the transaction. According to the footnotes, half of the options and half of the restricted stock units vest on each of the third and fourth anniversaries of the March 1, 2026 grant date.

Rhea-AI Summary

Chainey Kimberly reported acquisition or exercise transactions in this Form 4 filing.

Veralto Corp senior vice president and chief legal officer Kimberly Chainey reported equity awards consisting of stock options and restricted stock units. She received an employee stock option for 8,693 shares at a grant price of $0 and new grants of common stock tied to restricted stock units.

According to the award terms, one half of the options become exercisable on each of the third and fourth anniversaries of the March 1, 2026 grant date. The restricted stock units are payable solely in common stock and vest in installments over three and four years from the same grant date.

Rhea-AI Summary

Veralto Corp senior vice president Mattias Bystrom reported equity awards consisting of stock options and restricted stock units. He was granted 13,909 Director Stock Options with an exercise price of $0.00, and a separate award of 4,106 shares of common stock payable under restricted stock units.

According to the grant terms, one half of the options become exercisable on each of the third and fourth anniversaries of the March 1, 2026 grant date. One half of the restricted stock units vest on each of the third and fourth anniversaries of the same grant date, and the RSUs are payable solely in common stock.

Rhea-AI Summary

Veralto Corp senior vice president and chief human resources officer Lesley Beneteau reported equity awards in the form of stock options and restricted stock units. The filing shows a grant of 9,562 employee stock options with an exercise price of $0.00 per share, and a separate award of 2,823 shares of common stock payable under restricted stock units.

According to the disclosure, one half of the options and one half of the RSUs vest on each of the third and fourth anniversaries of the grant date of March 1, 2026. Following these awards, Beneteau directly holds 9,562 options and 20,269 shares of common stock, aligning her compensation more closely with Veralto's share performance over the long term.

Rhea-AI Summary

Veralto Corp senior executive Lesley Beneteau, SVP and CHRO, exercised employee stock options and handled related taxes using shares. On February 24, 2026, Beneteau exercised 7,004 stock options, acquiring the same number of Veralto common shares at $22.01 per share. A total of 3,503 common shares were then disposed of through tax-withholding transactions at $93.65 per share to cover exercise price or tax liabilities, not as open-market sales. After these transactions, Beneteau directly owned 17,446 Veralto common shares.

Rhea-AI Summary

Veralto Corp senior vice president of strategy and sustainability Surekha Trivedi reported a Form 4 transaction involving company common stock. On this Form 4, 1,192 shares were disposed of at $93.65 per share in a tax-withholding disposition related to satisfying tax obligations, not an open-market sale. Following this transaction, Trivedi directly owns 7,241 shares of Veralto common stock.

Rhea-AI Summary

Veralto Corp Chief Accounting Officer Bernard M. Skeete reported a tax-related share disposition. On the reported date, he disposed of 200 shares of common stock at $93.65 per share to cover tax withholding obligations. After this transaction, he directly holds 3,794 common shares.

Rhea-AI Summary

Veralto Corp senior vice president trades shares for tax withholding

Veralto Corp officer Melissa Kapity, SVP, Water Quality, reported a tax-withholding disposition of 2,114 shares of common stock on a Form 4. The shares were valued at $93.65 each for this transaction. After the disposition, she directly holds 15,320 Veralto common shares.

Rhea-AI Summary

Veralto Corp President and CEO Jennifer Honeycutt reported three tax-related share dispositions of common stock on February 24, 2026. These transactions, coded "F", were for 1,420, 1,283, and 5,900 shares at $93.65 per share to satisfy tax withholding obligations.

After these non‑market transactions, she directly held 97,142 shares of Veralto common stock. The filing also notes the underlying awards originated as Danaher performance stock units that were converted into Veralto restricted stock units in connection with the Veralto spin‑off.

Rhea-AI Summary

Veralto Corporation reported an annual deferred compensation contribution for executive Surekha Trivedi, SVP, Strategy & Sustainability. On February 5, 2026, Veralto credited 537 notional units in the Veralto Excess Contribution Program – Veralto Stock Fund at a price of $0 per unit.

These units represent company contributions (including match and nonelective amounts) deemed invested in unfunded, notional shares of Veralto common stock as of February 2, 2026, on a one-for-one basis. Following this transaction, Trivedi holds 2,695 notional derivative units directly under the plan, subject to the company’s deferred compensation program terms.

Rhea-AI Summary

Veralto Corporation’s Chief Accounting Officer, Bernard M. Skeete, reported an automatic award of derivative units tied to company stock through a deferred compensation plan. On February 5, 2026, his account received 255 notional shares under the Veralto Excess Contribution Program – Veralto Stock Fund at a price of $0 per unit.

These notional shares represent the Company’s annual contribution, including ECP match and nonelective contributions, and are deemed invested in Veralto common stock as of February 2, 2026. They convert into common shares on a one-for-one basis, bringing his total beneficial holdings in this plan-related derivative position to 420 notional shares, subject to vesting and distribution rules in Veralto’s deferred compensation program.

Rhea-AI Summary

Veralto Corporation reported that SVP and Chief Financial Officer Sameer Ralhan received an annual contribution under the Veralto Excess Contribution Program – Veralto Stock Fund. On February 5, 2026, his account was credited with 969 derivative units at $0 per unit, reflecting company contributions.

These units represent unfunded, notional shares of Veralto common stock deemed invested as of February 2, 2026, and convert on a one-for-one basis into common stock. After this transaction, Ralhan directly held 1,875 notional units under the program, which include matching and nonelective contributions subject to the program’s vesting and distribution terms.

Rhea-AI Summary

Veralto Corp President and CEO Jennifer Honeycutt reported receiving 2,766 notional shares linked to Veralto common stock through the company’s Executive Deferred Incentive Program on February 5, 2026. These notional shares represent the company’s annual contribution to her deferred compensation account and convert to common stock on a one-for-one basis under plan terms.

Following this contribution, Honeycutt beneficially owns 52,205 derivative securities tied to Veralto common stock in this deferred incentive program, held as direct ownership within her account.

Rhea-AI Summary

Veralto Corp (VLTO) senior vice president for PQI reported a routine stock sale. On 12/01/2025, the executive sold 1,000 shares of Veralto common stock at a price of $101.73 per share. After this transaction, the executive directly beneficially owns 31,430 shares of Veralto common stock. The filing is made on behalf of one reporting person and is signed by an attorney-in-fact.

Rhea-AI Summary

Veralto Corp (VLTO) reported an insider equity transaction by its SVP and Chief Human Resources Officer on 11/14/2025. The officer exercised an employee stock option to buy 1,622 shares of common stock at an exercise price of $23.64 per share, coded as an option exercise (M). To cover taxes or related obligations, 1,055 shares of common stock were disposed of at $98.78 per share, coded as a tax-related transaction (F). After these transactions, the officer directly beneficially owned 13,945 shares of Veralto common stock. The underlying employee stock option for 1,622 shares was fully exercised, leaving 0 derivative securities of that grant outstanding.

Rhea-AI Summary

Veralto Corp senior vice president and chief financial officer filed a Form 4 reporting a stock transaction in the company’s common stock. On 11/14/2025, the executive disposed of 3,361 shares of Veralto common stock at a price of $98.78 per share under transaction code F. After this transaction, the officer directly beneficially owned 49,686 shares of Veralto common stock.

Rhea-AI Summary

Veralto Corp (VLTO) executive reporting data shows a routine insider transaction. The company’s Chief Accounting Officer filed a Form 4 for activity on 11/14/2025. The filing reports the disposition of 93 shares of Veralto common stock, coded “F,” at a price of $98.78 per share, typically indicating shares withheld to cover taxes on an equity award. After this transaction, the officer directly owns 3,994 shares of Veralto common stock. The form is filed for a single reporting person and does not list any derivative securities activity.

Rhea-AI Summary

Jennifer Honeycutt, who serves as President and CEO and a director of Veralto Corp (VLTO), reported a sale of 474 shares of the issuer's common stock on 10/02/2025 at a reported price of $106.46 per share. After the transaction she is reported to beneficially own 105,745 shares in a direct capacity. The Form 4 discloses the sale code and shows the transaction was reported by an attorney-in-fact.